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Cryopreserved tissue allografts are thought to be lessimmunogenic than fresh allografts,1-3 but some
reports have suggested that graft degeneration may be
caused by immunologic rejection of the donor graft.4,5
The current procedure for tissue allograft cryopreser-
vation is focused on preserving the fibroblasts that
make up the matrices of allografts to increase graft
durability6,7; these cells are viable in situ even after
cryopreservation. In this study we focused on the allo-
genicity of fibroblasts and investigated the effect of
cryopreservation on them. The allogenicity-related
antigens expressed on the surface of the cells were
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assayed by using flow cytometry, and we simultane-
ously examined the effect of exogenous interferon-γ
(IFN-γ), which promotes the expression of major his-
tocompatibility complex antigens. Stimulation indices
(SIs) were also examined by 1-way mixed lympho-
cyte-fibroblast cell cultures (MLFCs), and the prolif-
eration indices (PIs) of fresh and cryopreserved
fibroblasts were examined by a colorimetric methyl-
thiazol-diphenyl-tetrazolium (MTT) assay.
Methods
Monoclonal antibodies. The monoclonal antibodies
(mAbs) used in this study were as follows: antifibroblast anti-
gen antibody (Ab-1: #CP28; Calbiochem, Cambridge, Mass),
fluorescein isothiocyanate (FITC)–conjugated anticytoker-
atin antibody (CAM 5.2: #347653; Becton-Dickinson
Immunocytometry System, San Jose, Calif), FITC-conjugat-
ed anti-HLA-1 antibody (#09HHLA01E; Sileus, Hawthorn,
Australia), phycoerythrin–conjugated anti-HLA-2 antibody
(#347367, Becton-Dickinson Immunocytometry System),
and anti-intercellular adhesion molecule (ICAM) 1 (CD54)
antibody (M7063; DAKO, Carpinteria, Calif). FITC-conju-
gated mouse anti-rat IgG mAb (F0479, DAKO) was used as
the second antibody for indirect immunofluorescence.
Preparation of the fibroblast strains and lymphocytes.
After the patients’ informed consent had been obtained,
fibroblasts were isolated from surgically resected human lung
tissue by means of enzymatic digestion (120 minutes at room
temperature) with 0.25% trypsin and 1 mmol/L ethylenedi-
amine tetraacetic acid (EDTA; #25200-056; Gibco BRL, Life
Technologies, Inc, Rockville, Md) and cultured at 37°C in a
75-cm2 Tissue Culture Flask (#3110-075; Iwaki Glass, Chiba,
Japan) with Roswell Park Memorial Institute (RPMI) medi-
um 1640 (#31800-022, Gibco BRL) containing 15% fetal
bovine serum (#26140-079, Gibco BRL) and 1% penicillin-
streptomycin (#15140-122, Gibco BRL) in an incubator filled
with 5% carbon dioxide. After 4 to 5 passages, the proliferat-
ed cells were identified as fibroblasts by means of flow cyto-
metric analysis of cell surface antigens with antifibroblast
antigen antibody, as described previously by Johnson and col-
leagues.8 BEAS-2B, a human airway epithelial cell line
(American Type Culture Collection registration number:
CRL-9609),9,10 and peripheral blood mononuclear cells
(PBMCs) were used as controls for the flow cytometric
analysis. The fibroblasts were used for further investigation.
PBMCs were separated from the blood of a healthy volunteer
by density centrifugation with Lymphoprep (#1001967;
Nycomed Pharma, Oslo, Norway).
Cryopreservation procedure. The fibroblasts were divid-
ed into 2 groups: a further-passaged group (fresh cells) and a
cryopreserved group (cryopreserved cells). The fibroblasts in
the cryopreserved group were conjugated in Medium 199
(#21200-076, Gibco BRL) containing 20% fetal bovine
serum and 10% dimethylsulfoxide (#134-06; Nacalai Tesque
Inc, Kyoto, Japan) and then frozen in a programmable freez-
er (Profreezer; NipponFreezer Co, Tokyo, Japan), as
described elsewhere.9 In brief, the specimen was cooled from
room temperature to 4°C at a rate of 3°C/min and then main-
tained at 4°C for 5 minutes. It was then cooled at 1°C/min
from 4°C to –50°C and at 5°C/min from –50°C to –80°C.
After the temperature of the specimen reached –80°C, it was
preserved at –130°C in the vapor phase of liquid nitrogen for
1, 4, and 24 weeks. The fibroblasts were then thawed rapidly
to 37°C. The passaged cells and the cryopreserved cells were
incubated for 48 hours in RPMI-1640 medium containing
15% fetal bovine serum and 1% penicillin-streptomycin with
and without IFN-γ (#13322-029, Gibco BRL; 100 ng/ml),
yielding the following 8 groups: fresh cells without IFN-γ;
fresh cells with IFN-γ; 1-week cryopreserved cells without
IFN-γ; 1-week cryopreserved cells with IFN-γ; 4-week cryo-
preserved cells without IFN-γ; 4-week cryopreserved cells
with IFN-γ; 24-week cryopreserved cells without IFN-γ; and
24-week cryopreserved cells with IFN-γ. Fibroblasts of the 8
groups prepared were then submitted to flow cytometric
analysis, and the freshly passaged cells and cryopreserved
cells, namely the fresh cells without IFN-γ, the 1-week cryo-
preserved cells without IFN-γ, the 4-week cryopreserved
cells without IFN-γ, and the 24-week cryopreserved cells
without IFN-γ, were investigated in regard to the following:
(1) stimulation indices in 1-way mixed lymphocyte-fibroblast
cell culture and (2) the proliferation indices of the cells.
Flow cytometric analysis. To identify fibroblasts, we exam-
ined the surface antigens of cultured proliferated cells by using
flow cytometric analysis, with BEAS-2B and PBMCs as con-
trols, and the surface HLA-1, HLA-2, and ICAM-1 molecules
on the fibroblasts of the 8 groups prepared as described above
were examined by flow cytometric analysis with a FACScalibur
system (Becton-Dickinson Immunocytometry System). After
incubation of 105 cells for 15 minutes at room temperature in
100 µL of phosphate-buffered saline solution (PBS) containing
10 µL of each mAb, the cells were washed and then incubated
for 15 minutes at room temperature in 100 µL of PBS contain-
ing the second antibody. After being washed, the cells were sus-
pended in 300 µL of PBS for flow cytometry, as reported pre-
viously.10 Each negative control specimen was conjugated in
the second antibody without the mAb.
One-way MLFC. MLFCs were made up of 1 × 106/mL
PBMCs and 1 × 105/mL fresh or cryopreserved fibroblasts
from the fresh cells without IFN-γ, 1-week cryopreserved
cells without IFN-γ, 4-week cryopreserved cells without IFN-
γ, and 24-week cryopreserved cells without IFN-γ groups
irradiated with 50 Gy and 50 µL of complete medium
(RPMI-1640 medium containing 15% fetal bovine serum and
1% penicillin-streptomycin). Cells were counted by the dye
exclusion method with 0.4% trypan blue (#15250-012, Gibco
BRL). The cells were cultured in a 96-well microplate
(MicrotestIII Tissue Culture Plate; #3072, Falcon, Becton-
Dickinson) in triplicate. The MLFCs were incubated for 72
hours at 37°C in 5% carbon dioxide. After incubation, a col-
orimetric MTT assay (CellTiter, #G4000; Promega, Madison,
Wis) was performed to determine the degree of proliferation,
as described elsewhere.10 In brief, 15 µL of dye solution was
added to each well followed by incubation for 4 hours under
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carbon dioxide, and 100 µL of stop solution was added to
each well. The absorbance at a wavelength of 570 nm, with a
reference wavelength of 630 nm, was measured with an
enzyme-linked immunosorbent assay plate reader (MTP-32
Microplate Reader; Corona Electric, Ibaraki, Japan). The
absorbance value was represented by a relative index, as fol-
lows: SI = (sample absorbance)/(control absorbance) × 100
(%), where the control absorbance value was that of the non-
stimulated PBMCs.
Fibroblast proliferation assay.  A colorimetric MTT
assay (CellTiter) was performed to determine the degree of
fibroblast proliferation. Cells were counted by using the dye
exclusion method with 0.4% trypan blue. Fibroblast cultures
were established with 1 × 106/mL fresh or cryopreserved
cells from the fresh cells without IFN-γ, 1-week cryopre-
served cells without IFN-γ, 4-week cryopreserved cells with-
out IFN-γ, and 24-week cryopreserved cells without IFN-γ
groups. A 50-µL volume of complete medium and 15 µL of
dye solution were added to each well in a 96-well microplate
in triplicate, and it was incubated for 4 hours at 37°C in 5%
carbon dioxide. At the end of the incubation period, 100 µL
of stop solution was added to each well, and the absorbance
at a wavelength of 570 nm was measured with an enzyme-
linked immunosorbent assay plate reader, with a reference
wavelength of 630 nm. The absorbance value was reported as
a relative index calculated as follows: PI = (sample
absorbance)/(control absorbance) × 100 (%), where the con-
trol absorbance value was that of the culture medium without
fibroblasts.
Statistical analysis. Data were analyzed with StatView J
5.0 (SAS Institute Inc, Cary, NC) on a Power Macintosh com-
puter (Apple Inc, Cupertino, Calif). All data are expressed as
means ± SEM (6 fibroblast cell strains per group). Data were
compared by 1-way or 2-way analysis of variance (ANOVA)
and the Fisher post hoc multiple comparison technique.
Results
Identification of fibroblasts. Six proliferating cell
strains were obtained from 11 lung tissue specimens.
The surface antigens of the cells were analyzed by flow
cytometry (Figs 1 and 2). They stained positive with
antifibroblast antigen antibody but stained negative
with anticytokeratin antibody and the second antibody.
The cells stained positive with anti-HLA-1 antibody
but not with anti-HLA-2 antibody. BEAS-2B was pos-
itive with anticytokeratin antibody but negative with
antifibroblast antigen antibody and the second anti-
body, and PBMCs were negative with antifibroblast
antigen antibody, anticytokeratin antibody, and the sec-
ond antibody. Antifibroblast antigen antibody (Ab-1) is
a novel fibroblast-specific mAb (AS02) that can be
used for detection and elimination of human fibro-
blasts. It shows no reactivity with keratinocytes, chon-
drocytes, smooth muscle cells, endothelial cells, or
Langerhans cells in situ and does not bind to extracel-
lular matrix proteins.11 The cell strains obtained were
positive with mAb AS02 and negative for anticytoker-
atin antibody, which stains epithelial-derived cells,
such as airway epithelial cells. The cells expressed only
HLA-1 and not HLA-2. Thus, the established cell
strains were considered to be somatic fibroblasts and
Fig 1. Histogram of flow cytometric analysis of isolated fibroblasts, BEAS-2B cells, and PBMCs. AS02,
Antifibroblast antigen; CAM5.2, anticytokeratin antibody.
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not antigen-presenting cells, such as vascular endothe-
lial cells, airway epithelial cells, or dendritic cells.
Flow cytometric analysis of fibroblasts. The fibro-
blasts cultured without IFN-γ expressed HLA-1 and
ICAM-1 on their cell surface but not HLA-2 (Tables I-
III). However, HLA-2 expression was induced on the
cell surface of the fibroblasts by addition of exogenous
IFN-γ (Fig 2).
The effects of cryopreservation and IFN-γ on expres-
sion of HLA-1, HLA-2, and ICAM-1 by fibroblasts
were as follows.
HLA-1. The mean intensity values of HLA-1 as a
measure of expression of the 8 groups and of their con-
trols are shown in Table I. The overall differences
among the 8 groups were determined by 1-way
ANOVA, and the P values were less than .0001.
Fibroblasts expressed HLA-1, and expression of HLA-
1 was not significantly changed by cryopreservation
(fresh cells without IFN-γ vs 1-week cryopreserved
cells without IFN-γ:P = .7687; fresh cells without IFN-
γ vs 4-week cryopreserved cells without IFN-γ:
P = .8071; fresh cells without IFN-γ vs 24-week cryo-
preserved cells without IFN-γ: P = .8913; fresh cells
with IFN-γ vs 1-week cryopreserved cells with IFN-γ:
P = .0611; fresh cells with IFN-γ vs 4-week cryopre-
served cells with IFN-γ: P = .3925; fresh cells with
IFN-γ vs 24-week cryopreserved cells with IFN-γ: P =
.1189) but was significantly enhanced by the addition
of IFN-γ (fresh cells without IFN-γ vs fresh cells with
IFN-γ: P = .0046; 1-week cryopreserved cells without
IFN-γ vs 1-week cryopreserved cells cells with IFN-γ:
P < .0001; 4-week cryopreserved cells without IFN-γ
vs 4-week cryopreserved cells with IFN-γ:
P = .0008; 24-week cryopreserved cells without IFN-γ
vs 24-week cryopreserved cells with IFN-γ: P < .0001).
Two-way ANOVA showed that the two factors (cryo-
Fig 2. Two-color analysis of expression of HLA-1 and HLA-2 on the fibroblast cell surface. IFN-γ–induced expres-
sion of HLA-2 is shown.
Table I. Mean intensity values for expression of HLA-1 on fibroblasts in the 8 groups
Fresh One-week Four-week Twenty-four–week
cells cryopreserved cells cryopreserved cells cryopreserved cells
Without IFN-γ
Mean intensity value 1731 ± 384* 1908 ± 308* 1878 ± 277* 1813 ± 348*
Control value 80 ± 19 141 ± 32 173 ± 23 104 ± 14
With IFN-γ
Mean intensity value 3528 ± 571* 4679 ± 507* 4044 ± 351* 4480 ± 532*
Control value 106 ± 11 143 ± 20 196 ± 32 105 ± 8
All data are expressed as means ± SEM.
*A significant difference from the control value.
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preservation and the addition of IFN-γ) did not yield
interaction terms (P = .6337). Cryopreservation did not
affect the expression of HLA-1 (P = .4400), whereas
addition of IFN-γ affected it significantly (P < .0001).
HLA-2. The mean intensity values of HLA-2 as a
measure of expression of the 8 groups and of their con-
trols are shown in Table II. The overall differences
among the 8 groups were determined by 1-way
ANOVA, and the P values were less than .0001.
Fibroblasts did not express HLA-2 unless stimulated
with IFN-γ, as shown in Table II (fresh cells without
IFN-γ vs control: P = .7749; 1-week cryopreserved cells
without IFN-γ vs control: P = .8510; 4-week cryopre-
served cells without IFN-γ vs control: P = .7926; 24-
week cryopreserved cells without IFN-γ vs control: P =
.8628). However, stimulation with IFN-γ significantly
induced the expression of HLA-2 (fresh cells with IFN-
γ vs control: P < .0001; 1-week cryopreserved cells with
IFN-γ vs control: P < .0001; 4-week cryopreserved cells
with IFN-γ vs control: P < .0001; 24-week cryopre-
served cells with IFN-γ vs control: P < .0001; fresh cells
without IFN-γ vs fresh cells with IFN-γ: P < .0001; 1-
week cryopreserved cells without IFN-γ vs 1-week cry-
opreserved cells with IFN-γ: P < .0001; 4-week cryo-
preserved cells without IFN-γ vs 4-week cryopreserved
cells with IFN-γ: P = .0003; 24-week cryopreserved
cells without IFN-γ vs 24-week cryopreserved cells
with IFN-γ: P < .0001). Cryopreservation did not alter
the expression of HLA-2 (fresh cells without IFN-γ vs
1-week cryopreserved cells without IFN-γ: P = .9849;
fresh cells without IFN-γ vs 4-week cryopreserved cells
without IFN-γ: P = .9873; fresh cells without IFN-γ vs
24-week cryopreserved cells without IFN-γ: P = .9279;
fresh cells with IFN-γ vs 1-week cryopreserved cells
with IFN-γ: P = .0588; fresh cells with IFN-γ vs 4-week
cryopreserved cells with IFN-γ: P = .1217; fresh cells
with IFN-γ vs 24-week cryopreserved cells with IFN-γ:
P = .1219). Two-way ANOVA showed that the two fac-
tors (cryopreservation and the addition of IFN-γ) did not
have interaction terms (P = .0600). Cryopreservation
did not affect the expression of HLA-2 (P = .0692), but
addition of IFN-γ affected it significantly (P < .0001).
ICAM-1. The mean intensity values of ICAM-1 as a
measure of expression of the 8 groups and of their con-
trols are shown in Table III. The overall differences
among the 8 groups were determined by 1-way
ANOVA, and the P values were less than .0001.
Fibroblasts expressed ICAM-1, and expression of
ICAM-1 was not significantly changed by cryopreser-
vation (fresh cells without IFN-γ vs 1-week cryopre-
served cells without IFN-γ: P = .6087; fresh cells with-
out IFN-γ vs 4-week cryopreserved cells without IFN-γ:
Table II. Mean intensity values for expression of HLA-2 on fibroblasts in the 8 groups
Fresh One-week Four-week Twenty-four–week
cells cryopreserved cells cryopreserved cells cryopreserved cells
Without IFN-γ
Mean intensity value 79 ± 19 74 ± 7 74 ± 16 53 ± 7
Control value 22 ± 5 36 ± 5 22 ± 3 18 ± 3
With IFN-γ
Mean intensity value 1654 ± 202* 2204 ± 372* 1206 ± 227* 2101 ± 298*
Control value 33 ± 7 40 ± 4 29 ± 3 25 ± 2
All data are expressed as means ± SEM.
*A significant difference from the control value.
Table III. Mean intensity values for expression of ICAM-1 on fibroblasts in the 8 groups
Fresh One-week Four-week Tkwenty-four–week
cells cryopreserved cells cryopreserved cells cryopreserved cells
Without IFN-γ
Mean intensity value 545 ± 90* 749 ± 149* 774 ± 115* 814 ± 119*
Control value 80 ± 19 141 ± 32 173 ± 23 104 ± 14
With IFN-γ
Mean intensity value 3064 ± 437* 3812 ± 494* 2688 ± 266* 2797 ± 250*
Control value 106 ± 11 143 ± 20 196 ± 32 105 ± 8
All data are expressed as means ± SEM.
*A significant difference from the control value.
P = .5663; fresh cells without IFN-γ vs 24-week cryo-
preserved cells without IFN-γ: P = .5008; fresh cells
with IFN-γ vs 1-week cryopreserved cells with IFN-γ :
P = .0657; fresh cells with IFN-γ vs 4-week cryopre-
served cells with IFN-γ : P = .3487; fresh cells with
IFN-γ vs 24-week cryopreserved cells with IFN-γ: P =
.5031), but it was significantly enhanced by the addition
of IFN-γ (fresh cells without IFN-γ vs fresh cells with
IFN-γ: P < .0001; 1-week cryopreserved cells without
IFN-γ vs 1-week cryopreserved cells with IFN-γ:
P < .0001; 4-week cryopreserved cells without IFN-γ vs
4-week cryopreserved cells with IFN-γ: P < .0001; 24-
week cryopreserved cells without IFN-γ vs 24-week
cryopreserved cells with IFN-γ: P < .0001). Two-way
ANOVA of the 2 factors (cryopreservation and the addi-
tion of IFN-γ) did not reveal interaction terms 
(P = .1569). Cryopreservation did not affect the expres-
sion of ICAM-1 (P = .1972), but addition of IFN-γ
affected it significantly (P < .0001).
Lymphocyte proliferation assay by MLFCs. SIs
were examined by MLFCs with a colorimetric MTT
assay, as described above. The SI of each group was as
follows: fresh cells without IFN-γ group, 1.716 ±
0.181; 1-week cryopreserved cells without IFN-γ
group, 1.382 ± 0.058; 4-week cryopreserved cells with-
out IFN-γ group, 1.567 ± 0.104; and 24-week cryopre-
served cells without IFN-γ group, 1.430 ± 0.101. One-
way ANOVA showed no significant differences among
the SIs of the 4 groups (P = .225).
Fibroblast proliferation assay. PIs were examined by
using a colorimetric MTT assay, as described above. The
PIs of the groups were as follows: fresh cells without
IFN-γ group, 8.802 ± 1.523; 1-week cryopreserved cells
without IFN-γ group, 6.863 ± 1.653; 4-week cryopre-
served cells without IFN-γ group, 7.575 ± 1.612; and 24-
week cryopreserved cells without IFN-γ group, 6.948 ±
1.476. One-way ANOVA showed no significant differ-
ences among the PIs of the 4 groups (P = .8067).
Comment
Because human tissue allografts, exquisitely con-
structed of many cell components, are structurally far
superior to prosthetic materials, and better methods of
cryopreservation have been developed, if there is no
immunologic rejection, cryopreserved human tissue
allografts may be the ideal material for certain recon-
structive procedures and can be available for clinical
use at any time by establishing tissue banking system.7
Cryopreservation of allograft tissues should make
them less immunogenic than fresh tissues. In actual fact,
cryopreserved cardiac valve allografts have been trans-
planted without immunosuppressants in many clinical
cases,7,12 as have cryopreserved tracheal allografts in
animal models.1-3 However, graft degeneration has been
observed in the late stage after allotransplantation of
cryopreserved tissues, such as cardiac valves, and some
authors have proposed that the degeneration is caused by
immunologic graft rejection.4,5 However, whether cryo-
preservation downregulates the allogenicity of grafts is a
matter of controversy. It is still unclear which component
of the graft is mainly responsible for the late rejection
phenomenon because the potent immunogenic compo-
nents of allografts, such as vascular endothelial cells or
airway epithelial cells, may be lost during the cryo-
preservation and thawing procedure2,13; cytokines
induced by inflammation after surgical intervention may
modify the immunologic reaction, and cryopreservation
itself may modify the allogenicity of the cells making up
the allograft.9,14,15
We hypothesized that cryopreservation affects the
allogenicity of cryopreserved cells making up allo-
graft tissues, and we examined the effect of cryo-
preservation on the allogenicity of human vascular
endothelial cells and human airway epithelial cells in
vitro, as previously reported elsewhere.9,14,15 The in
vitro experiments with a cell culture model revealed
that the allogenicity-related antigens expressed on
the cell surface can be modified by cryopreservation.
In brief, expression of HLA-2 antigens on human
vascular endothelial cells was upregulated by cryo-
preservation,14,15 but expression of HLA-2 antigens
on the human-derived airway epithelial cell line
BEAS-2B was downregulated.9
Current procedures for the cryopreservation of tissues
are aimed at maintaining the fibroblasts within the matrix
of the graft in good condition, thereby preserving the
graft itself, because it has been suggested that the cells
residing within the tissue matrix interstitium are impor-
tant to post-transplantation durability. In this experiment
we found that the fibroblast proliferation index was well
maintained even after 24 weeks of cryopreservation, and
this finding seems to support the current strategy.
Fibroblasts have been regarded as normal somatic
cells that express only HLA-1 antigens on their surface
and are far less potent immunologically. However, some
reports have shown that fibroblasts may disappear after
allotransplantation, suggesting rejection by the recipi-
ent.16,17 Our own results showed that fibroblasts were not
very immunogenic by examining stimulation indices in
a 1-way mixed lymphocyte-fibroblast cell culture.
However, the fact that the allogenicity of the fibroblasts
was maintained after cryopreservation, even after 24
weeks, and was upregulated by addition of IFN-γ seems
to be compatible with findings reported previously.
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Because IFN-γ is usually present during graft rejec-
tion,4,18 fibroblasts may trigger donor tissue rejection by
the recipient, even though they are immunologically less
potent under nonstimulated conditions than other anti-
gen-presenting cells, such as vascular endothelial cells,
airway epithelial cells, and dendritic cells. Besides
upregulation of HLA-2, enhancement of expression of
HLA-1 and ICAM-1, a costimulatory molecule,
expressed on the cell surface of fibroblasts may con-
tribute to stimulation of the recipient’s immune sys-
tem.10,19,20 Our findings appear to support other findings
on the relationship between fibroblasts making up the
matrix of implanted allografts and chronic rejection.
In contrast to our results suggesting persistent fibro-
blast immunogenicity, corneal fibroblasts and myofi-
broblasts have been shown to secrete a transforming
growth factor21 that is an inhibitor of HLA-2 expres-
sion,22 and this may contribute to the low degree of
immunogenicity of fibroblasts making up allograft tis-
sue.
Of course, tissue allografts consist of many types
of cells, and thus our findings regarding the fibro-
blasts present in abundance in cryopreserved allo-
grafts are considered to be only one factor in graft
rejection. Other mechanisms, such as loss of potent
immunogenic antigen-presenting cells during the
cryopreservation and thawing procedure or modifica-
tion of allogenicity expressed on the cell surface by cryo-
preservation, may also contribute to alterations in the
allogenicity of allografts and the resulting long-term
outcome.
Conclusion
Although the detailed mechanism of the long-term
degeneration of transplanted cryopreserved tissue allo-
grafts is still unclear, well-preserved fibroblasts within
the matrix of the allograft may contribute to this phe-
nomenon.
We thank Mr Chikuma Hamada of the Department of
Biostatistics for advice and assistance with statistical analysis.
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